|
EAGeR Trial - The Effects of Aspirin in Gestation and Reproduction Trial
|
Research Initiative
|
FDA
|
NICHD
|
|
|
|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC, HRSA
|
NIDCD
|
2007
|
|
|
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite with Coordinating Center
|
Research Initiative
|
HRSA
|
NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2019
|
|
|
Ebola Clinical Research Response in Democratic Republic of the Congo
|
Research Initiative
|
CDC, ASPR
|
NIAID
|
2018
|
|
|
Ebola Clinical Research Response in West Africa (Guinea, Liberia)
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
|
Ebola Vaccines Advisory Committee on Immunization Practices (ACIP) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
|
ECHO Institute and Project ECHO for Cancer Research and Control
|
Other
|
CDC
|
|
2017
|
|
|
Effective Data Management Subgroup of the Open Science Infrastructure Working Group of the Subcommittee on Open Science of the National Science and Technology Council Subcommittee on Open Science (NSTC OSTP SOS-EDM)
|
Committee, Advisory Group, or Work Group
|
ACL, ASPR, CDC
|
OD/ OSP
|
2019
|
|
|
EHE Operations Leadership Team (OLT)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, HRSA, IHS, SAMHSA, CMS
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
|
Emergency Preparedness, Medical Countermeasures (ASPR)
|
Resource Development
|
ASPR, CDC
|
|
2007
|
|
|
Emerging Contaminants and Issues of Concern Research Program
|
Research Initiative
|
CDC
|
NIEHS
|
|
|
|
Emerging Tobacco Products Communication Initiative Subject Matter Expert Work Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
|
End-stage Renal Disease Collaboration
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIBIB, NIDDK
|
2016
|
|
|
Ending the HIV Epidemic in the US administrative supplement announcement for NIH Centers for AIDS Research and NIMH AIDS Research Centers
|
Research Initiative
|
CDC, HRSA, Other
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NICHD
|
2003
|
|
|
Enhanced Federal Collaborations in Implementation Science and Research of HIV Prevention and Treatment
|
Other
|
CDC, HRSA
|
NIAID, NIMH
|
2022
|
|
|
Enhancing Scientific Collaboration between US and Colombia
|
Committee, Advisory Group, or Work Group
|
OGA
|
NIAID, FIC
|
2021
|
|
|
Environmental Phthalate Exposures In Pregnancy in Relation to Fetal and Placental Development
|
Research Initiative
|
CDC
|
|
2020
|
|
|
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
|
eRA Federal Shared Services (eRA)
|
Resource Development
|
AHRQ, FDA, SAMHSA, ASFR
|
OD/ OER
|
2016
|
|
|
Establishment of representative examination and dose repository for patients undergoing interventional fluoroscopic procedures
|
Research Initiative
|
FDA
|
|
2021
|
|
|
Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO RGN)
|
Research Initiative
|
HRSA
|
NHGRI
|
2021
|
|
|
Evaluation of Oropharyngeal responses to SARS-CoV-2
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
|
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
|
Evaluation of Visual Function in Animal Models
|
Research Initiative
|
FDA
|
NEI
|
|
|
